A vial of the Moderna Covid-19 vaccine and syringes sit prepared at a pop up vaccine clinic at the Jewish Community Center on April 16, 2021 in the Staten Island borough of New York City. Moderna is ...
Despite a U.S. factory mixup, more Johnson & Johnson doses are becoming available in the U.S., marking the only single-shot vaccine option. So how effective is it and how does it compare to the Pfizer ...
Pfizer (PFE) posted Q4 adjusted EPS of $0.66 beating the $0.57 consensus on $17.56B in revenue while its non-COVID portfolio grew 9% operationally, led by Abrysvo (+136%) and Lorbrena (+45%), plus a ...
A Fox News Instagram post suggests that Dr. Anthony Fauci, the president’s top medical adviser, was hypocritical in how he assessed a study on the effectiveness of the Pfizer and Moderna COVID-19 ...
The two New Jersey suits assert eight patents against Pfizer and 10 against Moderna, extending existing mRNA litigation beyond delivery technology to manufacturing, purity and non-COVID respiratory ...
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday’s close of $54.35. The intraday move extends what has ...
Pfizer (NYSE:PFE | PFE Price Prediction) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on a diversified non-COVID portfolio and a fresh push ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results